Tech Company Financing Transactions
Portal Instruments Funding Round
On 10/20/2015, Portal Instruments raised $25 million in Series B funding from 5AM Ventures, Sanofi-Genzyme BioVentures and private investors.
Transaction Overview
Company Name
Announced On
10/20/2015
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
5AM Ventures (Lead Investor) (James Young)
Sanofi-Genzyme BioVentures (Katherine Bowdish)
Proceeds Purpose
Proceeds from the Series B financing will be used to further develop Portal's groundbreaking computerized needle-free drug delivery system for injectable biologics for chronic diseases and to advance commercialization of its first product.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
190 5th St.
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Website
Email Address
Overview
Portal Instruments is a development stage, venture-backed company that is developing a unique platform technology to transform the delivery of modern medicines and improve the patient experience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Anquetil
Chief Operating Officer
Chris Barber
Vice President
Robert Gatewood
VP - Bus. Development
Wendy Dwyer
VP - Engineering
Bobby Dyer
VP - Marketing
Barbara Taylor
VP - Regulatory Affairs
Daniel Phelan
VP - Regulatory Affairs
Carla Sivak
Browse more venture capital transactions:
Prev: 10/20/2015: Surgical Theater venture capital transaction
Next: 10/20/2015: Vee24 venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs